---
title: "Vancomycin–Formyl Peptide Conjugate Binding to Resistant Staphylococcus aureus Measured by Flow Cy"
id: "pubmed-42555848"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42555848"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42555848/"
doi: "10.1002/cbic.70495"
published_at: "2026-08-14T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Vancomycin–Formyl Peptide Conjugate Binding to Resistant Staphylococcus aureus Measured by Flow Cy
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42555848
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42555848/)
- **DOI:** [10.1002/cbic.70495](https://doi.org/10.1002%2Fcbic.70495)
- **Published At:** 2026-08-14T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Staphylococcus aureus strains have developed resistance mechanisms that reduce the effectiveness of last‑resort antibiotics and impair immune clearance. - Modulating host immunity is a proposed strategy to combat antimicrobial resistance and improve infection elimination. - This work describes the development or assessment of an **immunotherapeutic** approach that links an antibiotic moiety (vancomycin) to a formyl peptide to target bacteria and engage immune responses. - The authors used **flow cytometry** to evaluate binding of a **vancomycin-formyl peptide conjugate** to the surface of resistant S. aureus. - The PubMed/NCBI record includes article metadata (authors, affiliations, PMID, PMCID, DOI) and links to full text, but the provided abstract in the source is truncated and does not report experimental details, quantitative results, or conclusions. - Specifics about conjugate synthesis, strains tested, flow‑cytometric parameters, binding metrics, functional immune outcomes, and statistical analyses were not reported in the excerpt available from the source. - The study appears in Chembiochem, and full text is available via PMC for readers seeking complete methods and findings. - Because the accessible source text is incomplete, no outcome statements, effect sizes, or recommendations can be drawn from the excerpt alone.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42555848/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42555848%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42555848/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42555848/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42555848/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/af7de7da-df5d-41c6-8de4-8c266af8ccfb/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42555848/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42555848/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42555848/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42555848%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42555848%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42555848/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42555848/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42555848/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42555848/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Wiley full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--media.wiley.com-assets-7388-69-wiley-full-text.png) Wiley ](https://doi.org/10.1002/cbic.70495 "See full text options at Wiley")[ Free PMC article ](https://pmc.ncbi.nlm.nih.gov/articles/pmid/42555848/ "Free full text at PubMed Central") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42555848/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42555848/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42555848/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42555848/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42555848/#conflict-of-interest) * [ Figures ](https://pubmed.ncbi.nlm.nih.gov/42555848/#figures) * [ References ](https://pubmed.ncbi.nlm.nih.gov/42555848/#references) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42555848/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42555848/#substances) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/42555848/#grants) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42555848/#linkout) Title & authors Abstract Conflict of interest statement Figures References MeSH terms Substances Grants and funding LinkOut - more resources Chembiochem Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Chembiochem%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Chembiochem%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42555848/) . 2026 Aug 14;27(15):e70495. doi: 10.1002/cbic.70495. # Assessing Vancomycin-Formyl Peptide Conjugate Binding to the Surface of Resistant Staphylococcus aureus via Flow Cytometry [Winfrey P Y Hoo](https://pubmed.ncbi.nlm.nih.gov/?term=Hoo+WPY&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia."), [Jemma Gullick](https://pubmed.ncbi.nlm.nih.gov/?term=Gullick+J&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia."), [Ryan F Leung](https://pubmed.ncbi.nlm.nih.gov/?term=Leung+RF&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia."), [Alex J Fulcher](https://pubmed.ncbi.nlm.nih.gov/?term=Fulcher+AJ&cauthor_id=42555848)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-3 "Monash Micro Imaging, Monash University, Clayton, Victoria, Australia."), [Rachel W Cass](https://pubmed.ncbi.nlm.nih.gov/?term=Cass+RW&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia."), [Julien Tailhades](https://pubmed.ncbi.nlm.nih.gov/?term=Tailhades+J&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia."), [Anton Y Peleg](https://pubmed.ncbi.nlm.nih.gov/?term=Peleg+AY&cauthor_id=42555848)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-4 "Infection Program, Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-5 "Centre to Impact AMR, Monash University, Clayton, Victoria, Australia.")[ 6 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-6 "Department of Infectious Diseases, Alfred Health and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia."), [Jennifer A E Payne](https://pubmed.ncbi.nlm.nih.gov/?term=Payne+JAE&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia.")[ 7 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-7 "Curiosity Factory Ltd., Surry Hills, New South Wales, Australia."), [Meredith O'Keeffe](https://pubmed.ncbi.nlm.nih.gov/?term=O%27Keeffe+M&cauthor_id=42555848)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-8 "Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia."), [Max J Cryle](https://pubmed.ncbi.nlm.nih.gov/?term=Cryle+MJ&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia.")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#full-view-affiliation-5 "Centre to Impact AMR, Monash University, Clayton, Victoria, Australia.") Affiliations Expand ### Affiliations * 1 Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. * 2 ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia. * 3 Monash Micro Imaging, Monash University, Clayton, Victoria, Australia. * 4 Infection Program, Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. * 5 Centre to Impact AMR, Monash University, Clayton, Victoria, Australia. * 6 Department of Infectious Diseases, Alfred Health and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia. * 7 Curiosity Factory Ltd., Surry Hills, New South Wales, Australia. * 8 Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. * PMID: **42555848** * PMCID: [ PMC13441204 ](https://pmc.ncbi.nlm.nih.gov/articles/PMC13441204/) * DOI: [ 10.1002/cbic.70495 ](https://doi.org/10.1002/cbic.70495) Item in Clipboard # Assessing Vancomycin-Formyl Peptide Conjugate Binding to the Surface of Resistant Staphylococcus aureus via Flow Cytometry Winfrey P Y Hoo et al. Chembiochem. 2026. Show details Display options Display options Format Abstract PubMed PMID Chembiochem Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Chembiochem%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Chembiochem%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42555848/) . 2026 Aug 14;27(15):e70495. doi: 10.1002/cbic.70495. ### Authors [Winfrey P Y Hoo](https://pubmed.ncbi.nlm.nih.gov/?term=Hoo+WPY&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia."), [Jemma Gullick](https://pubmed.ncbi.nlm.nih.gov/?term=Gullick+J&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia."), [Ryan F Leung](https://pubmed.ncbi.nlm.nih.gov/?term=Leung+RF&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia."), [Alex J Fulcher](https://pubmed.ncbi.nlm.nih.gov/?term=Fulcher+AJ&cauthor_id=42555848)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-3 "Monash Micro Imaging, Monash University, Clayton, Victoria, Australia."), [Rachel W Cass](https://pubmed.ncbi.nlm.nih.gov/?term=Cass+RW&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia."), [Julien Tailhades](https://pubmed.ncbi.nlm.nih.gov/?term=Tailhades+J&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia."), [Anton Y Peleg](https://pubmed.ncbi.nlm.nih.gov/?term=Peleg+AY&cauthor_id=42555848)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-4 "Infection Program, Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-5 "Centre to Impact AMR, Monash University, Clayton, Victoria, Australia.")[ 6 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-6 "Department of Infectious Diseases, Alfred Health and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia."), [Jennifer A E Payne](https://pubmed.ncbi.nlm.nih.gov/?term=Payne+JAE&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia.")[ 7 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-7 "Curiosity Factory Ltd., Surry Hills, New South Wales, Australia."), [Meredith O'Keeffe](https://pubmed.ncbi.nlm.nih.gov/?term=O%27Keeffe+M&cauthor_id=42555848)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-8 "Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia."), [Max J Cryle](https://pubmed.ncbi.nlm.nih.gov/?term=Cryle+MJ&cauthor_id=42555848)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-1 "Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-2 "ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia.")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42555848/#short-view-affiliation-5 "Centre to Impact AMR, Monash University, Clayton, Victoria, Australia.") ### Affiliations * 1 Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. * 2 ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria, Australia. * 3 Monash Micro Imaging, Monash University, Clayton, Victoria, Australia. * 4 Infection Program, Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. * 5 Centre to Impact AMR, Monash University, Clayton, Victoria, Australia. * 6 Department of Infectious Diseases, Alfred Health and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia. * 7 Curiosity Factory Ltd., Surry Hills, New South Wales, Australia. * 8 Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. * PMID: **42555848** * PMCID: [ PMC13441204 ](https://pmc.ncbi.nlm.nih.gov/articles/PMC13441204/) * DOI: [ 10.1002/cbic.70495 ](https://doi.org/10.1002/cbic.70495) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID ## Abstract Staphylococcus aureus strains have emerged with resistance mechanisms that reduce the efficacy of last resort antibiotics and evade the immune system. One strategy to combat antimicrobial resistance is to modulate host immunity to eliminate infections more effectively. This has led to the development of immunotherapeutics co
## Related Clinical Research

- [Early oral fecal microbiota transplantation versus vancomycin or fidaxomicin for first or first-re](https://medichelpline.com/clinical-feed/bmj-open-13-fecal-microbiota-transplantation-versus-vancomycin-or-fidaxomicin-in.md)
- [Citrobacter freundii Identified as Pathogen Causing Disease in Farmed Singhi (Heteropneustes fossi](https://medichelpline.com/clinical-feed/pubmed-42424302.md) (DOI: 10.1093/jahafs/vsag006)
- [Polystyrene microplastics increase Clostridioides difficile biofilms and reduce antibiotic suscept](https://medichelpline.com/clinical-feed/pubmed-42535848.md) (DOI: 10.1128/aem.01168-26)
- [Replace the term “red man syndrome” with vancomycin infusion reaction in clinical use](https://medichelpline.com/clinical-feed/cmaj-5-red-man-syndrome-should-never-be-used-to-describe-vancomycin-infusion-reaction.md)
- [Fresh fruit surfaces as reservoirs of multidrug-resistant, biofilm-forming Enterococcus faecalis](https://medichelpline.com/clinical-feed/plos-one-3-fresh-fruit-surface-a-potential-source-for-multidrug-resistant-biofilm-forming.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.